Actively Recruiting
Risk Assessment and Syndrome Evolution Models for Chronic Atrophic Gastritis Malignant Transformation
Led by Beijing University of Chinese Medicine · Updated on 2020-12-29
2000
Participants Needed
2
Research Sites
678 weeks
Total Duration
On this page
Sponsors
B
Beijing University of Chinese Medicine
Lead Sponsor
T
The University of Science and Technology of China
Collaborating Sponsor
AI-Summary
What this Trial Is About
Chronic atrophic gastritis (CAG) is acknowledged as the precancerous stage of gastric cancer (GC). The present study aims to developed risk assessment and syndrome evolution models of CAG malignant transformation events combining TCM indicators with modern medicine indicators. The proposed study is a registry study based participant survey conducted in 4 hospitals in Beijing, China. After obtaining informed consent, a total of 2000 study patients diagnosed with CAG will be recruited. 10-year follow-ups are carried out on-site in hospitals and off-site by telephone to track malignant transformation events.
CONDITIONS
Official Title
Risk Assessment and Syndrome Evolution Models for Chronic Atrophic Gastritis Malignant Transformation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 75 years
- Diagnosis of chronic atrophic gastritis confirmed by upper gastrointestinal endoscopy
- Willing to cooperate with data, tissue sample, and blood sample collection during recruitment
- Willing to respond truthfully and promptly to researcher questions and cooperate with sample collection during follow-ups
- Willing to sign informed consent
You will not qualify if you...
- History of previous stomach surgery
- Unable to participate in data, tissue sample, or blood sample collection for any reason
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Dongzhimen Hospital
Beijing, Beijing Municipality, China, 100029
Actively Recruiting
2
Wangjing Hospital
Beijing, Beijing Municipality, China, 100102
Actively Recruiting
Research Team
Y
Yin Zhang, MD
CONTACT
X
Xia Ding, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here